Common Problems in Liver Transplant Pathology
Keywords:
Liver Transplant; PathologyAbstract
No Abstract
References
1. Liver Transplantation. National Institutes of Health Consensus Development.
Nat Inst Health Consens Dev Conf Summ. 1983;4:15.
2. Berg CL, Steffick DE, Edwards EB, Heimbach JK, Magee JC, Washburn
WK, et al. Liver and intestine transplantation in the United States 1998-
2007. Am J Transplant. 2009 Apr;9(4 Pt 2):907-31.
3. Perez-Saborido B, Pacheco-Sanchez D, Barrera-Rebollo A, Sarmentero-
Prieto JC, Pinto-Fuentes P, Podriguez-Vielba P, et al. Eight years experience
with liver transplantation in Rio Hortega hospital. Transplant Proc. 2011
Apr;43(3):729-31.
4. Aberg F, Isoniemi H, Hockerstedt K. Long-term results of liver transplantation.
Scand J Surg. 2011;100(1):14-21.
5. Adam R, McMaster P, O’Grady JG, Castaing D, Klempnauer JL, Jamieson
N, et al. Evolution of liver transplantation in Europe: report of the European
liver transplant registry. Liver Transpl. 2003 Dec;9(12):1231-43.
6. Neuberger J. Developments in liver transplantation. Gut. 2004 May;53(5):
759-68.
7. McMaster P. Transplantation for alcoholic liver disease in an era of organ
shortage. Lancet. 2000 Feb 5;355(9202):424-5.
8. Farmer DG, Venick RS, McDiarmid SV, Ghobrial RM, Gordon SA,
Yersiz H, et al. Predictors of outcome after pediatric liver transplantation:
An analysis of over 800 cases performed at a single institution. J Am
Coll Surg. 2007 May;204(5):904-14.
9. Ayata G, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins R,
et al. Cryptogenic cirrhosis: clinicopathologic findings at and after liver
transplantaiton. Hum Pathol. 2002 Nov;33(11):1098-104.
10. Raphe R, Felicio HCC, Rocha MF, Duca WJ, Arroyo Jr PC, D’Santi
Neto D, et al. Histopathologic characteristics of incidental hepatocellular
carcinoma after liver transplantation. Transplant Proc. 2010 Mar;42(2):505-6.
11. Choi SH, Lee HH, Lee DS, Choi JH, Heo JS, Lee KW, et al. Clinicopathological
features of incidental Hepatocellular carcinoma in liver transplantation.
Transplant Proc. 2004 Oct;36(8):2293-4.
12. Garridoo MC, Hubscher SG. Accuracy of staging in primary biliary cirrhosis.
J Clin Pathol. 1996 Jul;49(7):556-9.
13. Harrison RF, Hubscher SG. The spectrum of bile duct lesions in end-stage
primary sclerosing cholangitis. Histopathology. 1991 Oct;19(4):321-7.
14. Squires RH Jr, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz
MR, et al. Acute liver failure in children: the first 348 patients in the
pediatric acute liver failure study group. J Pediatr. 2006 May;148(5):652-
658.
15. Hanau C, Munoz SJ, Rubin R. Histopathological heterogeneity in fulminant
hepatic failure. Hepatology. 1995 Feb;21(2):345-51.
16. Mazzaferro V, Regalio E, Doci R, Andreola S, Pulvirenti A, Bozzetti F,
et al. Liver transplantation for the treatment of small hepatocellular carcinomas
in patients with cirrhosis. N Engl J Med. 1996 Mar 14;334(11):
693-9.
17. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al.
Liver transplantation for hepatocellular carcinoma: expansion the tumor
size limites does not adversely impact survival. Hepatology. 2001 Jun;33
(6):1394-403.
18. Bartlett AS, Ramadas R, Furness S, Gane E, McCall JL. The natural
history of acute histologic rejection without biochemical graft dysfunction
in orthotopic liver transplantation: a systematic review. Liver Transpl.
2002 Dec;8(12):1147-53.
19. Therapondos G, Hayes PC. Is this the end for protocol early posttransplant
liver biopsies? Liver Transpl. 2002 Dec;8(12):1154-5.
20. Wiesner RH, Demetris AJ, Belle SH, Seaberg EC, Lake JR, Zetterman
RK, et al. Acute hepatic allograft rejectin: incidence, risk factors, an
impact on outcome. Hepatology. 1998 Sep;28(3):638-45.
21. Ludwig J, Wiesner RH, Batts KP, Perkins JD, Krom RA. The acute
vanishing bile duct syndrome (acute irreversible rejection) after orthotopic
liver transplantation. Hepatology. 1987 May-Jun;7(3):476-83.
22. Devlin J, Page AC, O’Grady J, Portmann B, Karani J, Wiliams R. Angiographically
determined arteriopathy in liver graft dysfunction and survival.
J Hepatol. 1993 Apr;18(1):68-73.
23. International Panel. Banff schema for grading liver allograft rejection:
an international consensus document. Hepatology. 1997 Mar;25(3):658-63.
24. Oh CK, Pelletier SJ, Sawyer RG, Dacus AR, McCullough CS, Pruett
TL, et al. Uni- and multi-variate analysis of risk factors for early and
late hepatic artery thrombosis after liver transplantation. Transplantation.
2001 Mar 27;71(6):767-72.
25. Ludwig J, Batts KP, MacCarty RL. Ischemic cholangitis in hepatic allografts.
Mayo Clin Proc. 1992 Jun;67(6):519-26.
26. Guichelaar MM, Benson JT, Malinchoc M, Krom RA, Wiesner RH,
Charlton MR. Risk factors for and clinical course of non-anastomotic
biliary strictures after liver transplantation. Am J Transplant. 2003 Jul;3
(7):885-90.
27. Sanchez-Urdazpal L, Gores GJ, Ward EM, Maus TP, Wahlstrom HE,
Moore SB, et al. Ischemic-type biliary complication after orthotopic liver
transplantation. Hepatology. 1992 Jul;16(1):49-53.
28. Roche B, Samuel D. Evolving strategies to prevent HBV recurrence.
Liver Transpl. 2004 Oct;10(10 Suppl 2):S74-85.
29. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP,
et al. Liver transplantation in European patients with the hepatitis B
surface antigen. N Engl J Med. 1993 Dec 16;329(25):1842-7.
30. McCaughan GW, Zekry A. Pathogenesis of hepatitis C virus recurrence
in the liver allograft. Liver Transpl. 2002 Oct;8(10 Suppl 1):S7-S13.
Nat Inst Health Consens Dev Conf Summ. 1983;4:15.
2. Berg CL, Steffick DE, Edwards EB, Heimbach JK, Magee JC, Washburn
WK, et al. Liver and intestine transplantation in the United States 1998-
2007. Am J Transplant. 2009 Apr;9(4 Pt 2):907-31.
3. Perez-Saborido B, Pacheco-Sanchez D, Barrera-Rebollo A, Sarmentero-
Prieto JC, Pinto-Fuentes P, Podriguez-Vielba P, et al. Eight years experience
with liver transplantation in Rio Hortega hospital. Transplant Proc. 2011
Apr;43(3):729-31.
4. Aberg F, Isoniemi H, Hockerstedt K. Long-term results of liver transplantation.
Scand J Surg. 2011;100(1):14-21.
5. Adam R, McMaster P, O’Grady JG, Castaing D, Klempnauer JL, Jamieson
N, et al. Evolution of liver transplantation in Europe: report of the European
liver transplant registry. Liver Transpl. 2003 Dec;9(12):1231-43.
6. Neuberger J. Developments in liver transplantation. Gut. 2004 May;53(5):
759-68.
7. McMaster P. Transplantation for alcoholic liver disease in an era of organ
shortage. Lancet. 2000 Feb 5;355(9202):424-5.
8. Farmer DG, Venick RS, McDiarmid SV, Ghobrial RM, Gordon SA,
Yersiz H, et al. Predictors of outcome after pediatric liver transplantation:
An analysis of over 800 cases performed at a single institution. J Am
Coll Surg. 2007 May;204(5):904-14.
9. Ayata G, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins R,
et al. Cryptogenic cirrhosis: clinicopathologic findings at and after liver
transplantaiton. Hum Pathol. 2002 Nov;33(11):1098-104.
10. Raphe R, Felicio HCC, Rocha MF, Duca WJ, Arroyo Jr PC, D’Santi
Neto D, et al. Histopathologic characteristics of incidental hepatocellular
carcinoma after liver transplantation. Transplant Proc. 2010 Mar;42(2):505-6.
11. Choi SH, Lee HH, Lee DS, Choi JH, Heo JS, Lee KW, et al. Clinicopathological
features of incidental Hepatocellular carcinoma in liver transplantation.
Transplant Proc. 2004 Oct;36(8):2293-4.
12. Garridoo MC, Hubscher SG. Accuracy of staging in primary biliary cirrhosis.
J Clin Pathol. 1996 Jul;49(7):556-9.
13. Harrison RF, Hubscher SG. The spectrum of bile duct lesions in end-stage
primary sclerosing cholangitis. Histopathology. 1991 Oct;19(4):321-7.
14. Squires RH Jr, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz
MR, et al. Acute liver failure in children: the first 348 patients in the
pediatric acute liver failure study group. J Pediatr. 2006 May;148(5):652-
658.
15. Hanau C, Munoz SJ, Rubin R. Histopathological heterogeneity in fulminant
hepatic failure. Hepatology. 1995 Feb;21(2):345-51.
16. Mazzaferro V, Regalio E, Doci R, Andreola S, Pulvirenti A, Bozzetti F,
et al. Liver transplantation for the treatment of small hepatocellular carcinomas
in patients with cirrhosis. N Engl J Med. 1996 Mar 14;334(11):
693-9.
17. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al.
Liver transplantation for hepatocellular carcinoma: expansion the tumor
size limites does not adversely impact survival. Hepatology. 2001 Jun;33
(6):1394-403.
18. Bartlett AS, Ramadas R, Furness S, Gane E, McCall JL. The natural
history of acute histologic rejection without biochemical graft dysfunction
in orthotopic liver transplantation: a systematic review. Liver Transpl.
2002 Dec;8(12):1147-53.
19. Therapondos G, Hayes PC. Is this the end for protocol early posttransplant
liver biopsies? Liver Transpl. 2002 Dec;8(12):1154-5.
20. Wiesner RH, Demetris AJ, Belle SH, Seaberg EC, Lake JR, Zetterman
RK, et al. Acute hepatic allograft rejectin: incidence, risk factors, an
impact on outcome. Hepatology. 1998 Sep;28(3):638-45.
21. Ludwig J, Wiesner RH, Batts KP, Perkins JD, Krom RA. The acute
vanishing bile duct syndrome (acute irreversible rejection) after orthotopic
liver transplantation. Hepatology. 1987 May-Jun;7(3):476-83.
22. Devlin J, Page AC, O’Grady J, Portmann B, Karani J, Wiliams R. Angiographically
determined arteriopathy in liver graft dysfunction and survival.
J Hepatol. 1993 Apr;18(1):68-73.
23. International Panel. Banff schema for grading liver allograft rejection:
an international consensus document. Hepatology. 1997 Mar;25(3):658-63.
24. Oh CK, Pelletier SJ, Sawyer RG, Dacus AR, McCullough CS, Pruett
TL, et al. Uni- and multi-variate analysis of risk factors for early and
late hepatic artery thrombosis after liver transplantation. Transplantation.
2001 Mar 27;71(6):767-72.
25. Ludwig J, Batts KP, MacCarty RL. Ischemic cholangitis in hepatic allografts.
Mayo Clin Proc. 1992 Jun;67(6):519-26.
26. Guichelaar MM, Benson JT, Malinchoc M, Krom RA, Wiesner RH,
Charlton MR. Risk factors for and clinical course of non-anastomotic
biliary strictures after liver transplantation. Am J Transplant. 2003 Jul;3
(7):885-90.
27. Sanchez-Urdazpal L, Gores GJ, Ward EM, Maus TP, Wahlstrom HE,
Moore SB, et al. Ischemic-type biliary complication after orthotopic liver
transplantation. Hepatology. 1992 Jul;16(1):49-53.
28. Roche B, Samuel D. Evolving strategies to prevent HBV recurrence.
Liver Transpl. 2004 Oct;10(10 Suppl 2):S74-85.
29. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP,
et al. Liver transplantation in European patients with the hepatitis B
surface antigen. N Engl J Med. 1993 Dec 16;329(25):1842-7.
30. McCaughan GW, Zekry A. Pathogenesis of hepatitis C virus recurrence
in the liver allograft. Liver Transpl. 2002 Oct;8(10 Suppl 1):S7-S13.
Downloads
Published
03-04-2020
How to Cite
Pongpaibul, A. . (2020). Common Problems in Liver Transplant Pathology. Siriraj Medical Journal, 63(6), 210–214. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/241539
Issue
Section
Review Article
License
Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:
- Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
